| ORIGINAL ARTICLE |
|
| Year : 2015 | Volume
: 7
| Issue : 1 | Page : 66-73 |
|
|
Evaluation of antitumor activity and antioxidant status of Alternanthera brasiliana against Ehrlich ascites carcinoma in Swiss albino mice
Pavan Kumar Samudrala1, Bibin Baby Augustine1, Eshvendar Reddy Kasala1, Lakshmi Narendra Bodduluru1, Chandana Barua2, Mangala Lahkar3
1 Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research Guwahati (NIPER Guwahati), India
2 College of Veterinary Sciences (CVSc), Khanapara, India
3 Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research Guwahati (NIPER Guwahati); 3Pharmacology, Gauhati Medical College, Bhangagarh, Guwahati, India
Correspondence Address:
Pavan Kumar Samudrala
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Guwahati, GMC IIIrd Floor, Bhangagarh, Guwahati - 781 032
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-8490.147211
|
|
|
Objective : The main objective of the present study was to explore the antitumor activity of the ethyl acetate extract of the Alternanthera brasiliana (EAAB) and its antioxidant status against Ehrlich ascites carcinoma (EAC) in Swiss albino mice. Materials and Methods: Based on the preliminary in vitro cytotoxicity studies, EAAB was selected for anti-tumor and antioxidant effects. Anticancer activity of EAAB was evaluated against EAC in Swiss albino mice at the doses of 200 and 400 mg/kg. EAAB was administered for 14 consecutive days after induction of cancer. After 24 h of the last dose and 18 h of fasting, half of the mice were sacrificed and rest were kept alive for assessing any increase in life span. The antitumor effect of EAAB was assessed by evaluating tumor volume, viable and nonviable tumor cell count, tumor weight, hematological and biochemical parameters of EAC bearing host. Furthermore, the antioxidant and histopathological parameters were evaluated. Results: EAAB treatment has shown significant decrease in tumor volume, viable cell count, tumor weight and elevated the life span of EAC tumor bearing mice in a dose dependent manner. In hematological profile count of RBC, hemoglobin, and WBC were found reverted to normal. EAAB also significantly decreased the levels of lipid peroxidation and significantly increased the levels of GSH, SOD and Catalase. Conclusion: From the above results it may be concluded that EAAB has potent dose dependent antitumor activity and is comparable to that of 5-flourouracil. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
